Efficacy and Safety of Two Different Botulinum Toxin Type A Treatments for Moderate to Severe Cervical Dystonia

Study Identifier
MedAff-BTX-0615
CT.gov Identifier
NCT00432341
EudraCT Identifier
Not available
EUCTIS ID
Not available
For general inquiries, please contact

844-663-3742 or [email protected]

Other
Sign up for trial alerts

Study Details

Medical Condition
  • Movement Disorders - Other
    • Study Drug
  • botulinum toxin type A
    • Phase
    Phase 4
    Sex
    Female & Male
    Age
    18 - 75 Years
    Inclusion and Exclusion Criteria
    Inclusion Criteria:
    * Diagnosed with cervical dystonia/spasmodic torticollis for at least 18 months * Successfully treated previously with botulinum toxin type A
    Exclusion Criteria:
    * Breast feeding, pregnant, or could become pregnant * Surgery or spinal cord stimulation for cervical dystonia * Previous injections of phenol, alcohol for cervical dystonia

    Protocol Summary

    The purpose of this study is to compare two types of botulinum toxin type A to treat the involuntary muscle contractions in the neck

    Study Locations

    Location
    Status
    Location
    Buenos Aires, Argentina
    Status
    Not applicable
    Location
    Parkville, Victoria, Australia
    Status
    Not applicable
    Location
    New Delhi, New Delhi, India
    Status
    Not applicable